3rd International Symposium on Cancer, microRNAs, and other non-coding RNAs

September 10, 2012

Very last minute – but if you are near London and don’t have any plans for Wednesday this might be right event for you: The third international symposium on Cancer, microRNAs and other non-coding RNAs will highlight the function and regulation of non-coding RNAs during oncogenesis. The symposium will cover a wide range of themes, […]

Read the full article →

Upcoming Cancer microRNA Webinar

July 9, 2012

Title: Recent Work & Current Methods in Cancer microRNA Research – The 2nd in a series of microRNA Webinars presented by LC Sciences Date: Wed 7/11/12 Please register for the webinar by selecting the presentation time that is most convenient for your timezone. North America  – 1:00 Central Daylight Time Europe – 1:00 PM Greenwich […]

Read the full article →

Keystone Symposium: Noncoding RNAs in Development and Cancer

June 27, 2012

Date and Location: January 20—25, 2013 Fairmont Hotel Vancouver, Vancouver, British Columbia, Canada Meeting Summary: A recurrent principle in cancer biology is the co-option of pathways that function during development to promote aberrant tumor cell behavior. This principle clearly applies to the roles of noncoding RNAs in cancer. Examples of noncoding RNAs that modify tumor […]

Read the full article →

OncomiRs: New miRNA & Cancer Focused Open Access Journal

May 18, 2012

OncomiRs is a new open access journal from Emerging Science Journal program, launched recently by Versita. The journal will publish original research articles and reviews covering all the basics aspects of the microRNAs implication in tumor formation and development as well as their role in the treatment sensitivity and resistance. The OncomiRs’ focus lies on […]

Read the full article →

International Workshop on Small RNA in Cancer Inflammation and Aging

May 10, 2012

Dates: from 03 September 2012 12:00 to 04 September 2012 17:00 Timezone: Europe/Copenhagen Location: Eigtveds Pakhus, Copenhagen, Denmark Registration closes on August 24, 2012. Abstract submissions are due by August 01, 2012 Confirmed speakers include: Aaron J. Schetter Anders H. Lund Carlo M. Croce Curtis C. Harris Hadi Valadi Heiko Hermeking Henrik Ørum Jan Gorodkin […]

Read the full article →

Microcosmos of Cancer: A Mini Review

February 21, 2012

In this week’s issue of Nature , two researchers at the Cancer Biology and Genetics Program, Memorial Sloan-Kettering Cancer Center have published a review discussing the diverse contribution microRNA networks exhibit in cancer biology. Lujambio et. al. discuss both the oncogenic and tumor-suppressor roles microRNA have been attributed in the initiation and progression of multiple […]

Read the full article →

miR-375 a potential prognostic marker of head and neck cancers

January 25, 2012

Low-Level Expression of miR-375 Correlates with Poor Outcome and Metastasis While Altering the Invasive Properties of Head and Neck Squamous Cell Carcinomas. Researchers at Department of Pathology, Albert Einstein College of Medicine used global miRNA expression profiling of head and neck squamous cell carcinoma (HNSCC) samples and adjacent normal tissue to rank those miRNAs that […]

Read the full article →

Rosetta Genomics Announces New York State Approval for miRview mets²

December 9, 2011

Proprietary microRNA Diagnostic for Identification of Cancer of Unknown Primary Now Available in All 50 U.S. States PHILADELPHIA, PA and REHOVOT, ISRAEL–(Marketwire – Dec 9, 2011) – Rosetta Genomics, Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announced that the New York State Department of Health has approved miRview® mets² for […]

Read the full article →

Plasma Components Affect Accuracy of Circulating Cancer-Related MicroRNA Quantitation

December 7, 2011

New protocols improve detection of microRNAs for diagnosis Philadelphia, PA, — MicroRNAs (miRNAs) that regulate processes including fertilization, development, and aging show promise as biomarkers of disease. They can be collected from routinely collected fluids such as blood, saliva, and urine. However, a number of factors can interfere with the accuracy of miRNA tests. In […]

Read the full article →

Study Shows Potential for microRNAs to Predict Gastric Cancer Recurrence

November 4, 2011

AIM: To compare the microRNA (miR) profiles in the primary tumor of patients with recurrent and non-recurrent gastric cancer. CONCLUSION: This study identified three miRs, miR-451, miR-199a-3p and miR-195 to be predictive of recurrence of gastric cancer. Of these, miR-451 had the strongest prognostic impact. PHILADELPHIA and REHOVOT, Israel, Nov. 4, 2011 /PRNewswire/ — Rosetta […]

Read the full article →